KAIST researchers isolated DDX54 as the master regulator that hinders the effectiveness of immunotherapy—opening a new path ...

Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to ...

The following is a summary of “Mediating effects of coping strategies between symptom clusters and quality of life in lung ...

MIAMI, FLORIDA (April 9, 2025) – A clinical trial for patients with high-grade neuroendocrine tumors is now open for ...

Dr. Lillian L. Siu discussed potential risk factors and treatment strategies associated for patients with head and neck ...

The US Food and Drug Administration (FDA) has granted clearance to CureVac's investigational new drug application (IND) for ...

Brian McNamara has a shot at beating his aggressive cancer, but his Aetna subsidiary insurance company doesn't want to pay ...

12, 2024 — Researchers examined the impact of obesity in relation to treatment and mortality from data on over 500,000 lung cancer patients. This study suggests that immunotherapy may not be the ...

BioNTech has shown why it made small cell lung cancer (SCLC) a priority for its PD-L1xVEGF-A bispecific. | BioNTech has shown ...

Real-world experiences and treatments for lung cancer and head & neck cancer were shared at scientific conferences entitled ...

TAIPEI (Taiwan News) — A study by Chang Gung Memorial Hospital has discovered that removing the amino acid asparagine from ...